TumCG Cancer Research Results

TumCG, Tumor cell growth: Click to Expand ⟱
Source:
Type:
Normal cells grow and divide in a regulated manner through the cell cycle, which consists of phases (G1, S, G2, and M).
Cancer cells often bypass these regulatory mechanisms, leading to uncontrolled proliferation. This can result from mutations in genes that control the cell cycle, such as oncogenes (which promote cell division) and tumor suppressor genes (which inhibit cell division).


Scientific Papers found: Click to Expand⟱
8569- Matr,    Matrine inhibits the metastatic properties of human cervical cancer cells via downregulating the p38 signaling pathway
- vitro+vivo, Cerv, NA
TumCG↓, Apoptosis↑, TumCI↓, TumCMig↓, MMP2↓, MMP9↓, p38↓, TumCG↓, TumMeta↓,
8570- Matr,    Matrine suppresses invasion of castration-resistant prostate cancer cells by downregulating MMP-2/9 via NF-κB signaling pathway
- vitro+vivo, Pca, DU145 - in-vitro, Pca, PC3
TumCG↓, TumCMig↓, TumCI↓, MMP9↓, MMP2↓, p‑p65↓, NF-kB↓,
8574- Matr,    Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration
- in-vitro, Lung, A549 - ex-vivo, HCC, SMMC-7721 cell
TumCG↓, Bcl-2↓, BAX↑, TumCMig↓, tumCV∅, VEGF↓, Synergy↑,
8542- Matr,    Matrine Suppresses Lung Cancer Progression via Dual Inhibition of CHEK1-Mediated DNA Damage Repair and PI3K/AKT Survival Signaling
- vitro+vivo, Lung, A549
TumCP↓, TumCMig↓, TumCI↓, TumCCA↑, p‑PI3K↓, CHK1↓, p‑Akt↓, Bcl-2↓, MTA1↓, Vim↓, MMP2↓, MMP9↓, γH2AX↑, E-cadherin↑, BAX↑, cl‑Casp3↑, Ki-67↓, TumCG↓,
8537- Matr,    Matrine restrains the development of colorectal cancer through regulating the AGRN/Wnt/β-catenin pathway
- vitro+vivo, CRC, NA
TumCG↓, AGRN↓, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, Wnt↓, β-catenin/ZEB1↓,
8535- Matr,    Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel
- in-vitro, Cerv, NA
TumCG↓, *toxicity↓, Ferroptosis↑, GPx4↓, lipid-P↑, Iron↓, ROS↑, Piezo1↑,
8558- Matr,    Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells
- in-vitro, BC, MCF7
TumCG↓, TumAuto↑, LC3B-II↑, p62↓, Akt↓, mTOR↓,
8628- MBZ,    Mebendazole induces apoptosis and inhibits migration via the reactive oxygen species-mediated STAT3 signaling downregulation in non-small cell lung cancer
- vitro+vivo, Lung, A549 - in-vitro, Lung, H460
TumCP↓, TumCMig↓, Apoptosis↑, ROS↑, p‑JAK2↓, p‑STAT3↓, eff↓, TumCG?, Bcl-xL↓, EMT↓, Snail↓, Twist↓,
8629- MBZ,    Repurposing the antihelmintic mebendazole as a hedgehog inhibitor
- in-vitro, Nor, NIH-3T3 - vitro+vivo, GBM, GL-15 - in-vitro, GC, DAOY
HH↓, TumCG↓, Synergy↑, Dose↝, Gli1↓, PTCH1↓, α-tubulin↓, Smo↓, toxicity↓, Half-Life↝, toxicity↝,
8635- MBZ,    The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma
- vitro+vivo, Melanoma, NA
TumCCA↑, cMyc↓, cl‑Casp3↑, cl‑PARP↑, eff↑, TumCP↓, BRAF↓, OS↑, TumCG↓, p‑MEK↓, p‑ERK↓,
8636- MBZ,    Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer
- in-vivo, Ovarian, SKOV3
TumCG?, P53↑, P21↑, Synergy↑, Dose↝,
8655- MBZ,    Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells
- in-vitro, Melanoma, NA
TubPol↓, Apoptosis↑, TumCG↓, Bcl-2?, selectivity↑,
8648- MBZ,    Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- Review, Var, NA
angioG↓, MMPs↓, MDR1↓, TubPol↓, RadioS?, ChemoSen?, TumCG↓, TumMeta?, OS↑, BioAv↓, BioAv↑, BBB↑, mitA↑, HH↓, Shh↓, Synergy↑, Gli1↓, PTCH2↓, XIAP↓, cl‑PARP↑, Casp3↑, BRAF↓, MEK↓, SYN1↑, Cyt‑c↑, TumVol↓, VEGFR2/KDR/Flk1↓, VEGF↓, VCAM-1↓, DYRK1B↓, QoL↑, Dose↝,
2500- MBZ,    Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
- in-vitro, GBM, U87MG - in-vivo, GBM, NA
α-tubulin↓, AntiCan↑, TumCG↓, OS↑, VEGF↓, Hif1a↓,
2488- mCHEMO,    Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma
- in-vitro, HCC, HUH7 - in-vivo, HCC, NA
TumCG↓, toxicity↓, OS↑, TSP-1↑, Dose↓, Dose↓,
8784- mCHEMO,    Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells
- Review, Var, NA
Dose↝, TumCG↓, angioG↓, TSP-1↑, CD133↓, CSCs↓,
8816- MCP,    Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment
- vitro+vivo, BC, MDA-MB-231 - in-vitro, BC, 4T1
GlucoseCon↓, GLUT1↓, Gal-3↓, ROS↓, NRF2↓, Hif1a↓, angioG↓, pol-M2 MC↓, p‑STAT3↓, TumCG↓, TumW↓,
8812- MCP,    Investigation of Antitumor Activity of Modified Citrus Pectin: Oral and Intravenous Administration Assessed via Molecular Imaging
- vitro+vivo, Ovarian, SKOV3 - in-vitro, GC, MKN-28 - in-vitro, BC, 4T1
BioAv↓, TumCG↓, eff↓,
8822- MCP,    Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3
- vitro+vivo, CRC, T24/HTB-9 - in-vitro, Bladder, J82
TumCCA↑, cycD1/CCND1↓, p‑cDC2↓, Casp3↑, cl‑Casp3↑, cl‑PARP↑, Gal-3↓, Akt↓, TumCG↓, Ki-67↓, Dose⇅,
8622- MCT,    Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model
- vitro+vivo, HCC, NA
AntiTum↑, HGF/c-Met↓, TumCG↓, TumMeta↓,
8715- MeJa,    Methyl jasmonate decreases membrane fluidity and induces apoptosis via tumor necrosis factor receptor 1 in breast cancer cells
- in-vitro, BC, MDA-MB-453 - in-vitro, BC, MCF-10AT
TumCG↓, TumCCA↑, memfluid↓, TNFR 1↑, MAPK↑, Casp8↑, MMP↓, Apoptosis↑, p38↑, ERK↑, Casp3↑,
8751- MeSA,  PacT,    Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer
- vitro+vivo, BC, MDA-MB-231
ChemoSen↑, Casp↑, Apoptosis↑, TumCCA↑, TumCP↓, TumCG↓,
8753- MeSA,    Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis
- vitro+vivo, GBM, U251 - in-vitro, GBM, U87MG
Apoptosis↑, Casp7↑, Casp9↑, Casp3↑, ROS↑, TumCG↓,
8755- MeSA,    The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice
- in-vivo, CRC, NA
TumCG↓, Dose↝, GPx↑, TNF-α↓, IL6↓,
8749- MeSA,  etoposide,    Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo
- in-vivo, Pca, NA
TumCG↓, Apoptosis↑, p‑ERK↓, p‑Akt↓, FABP5/E-FABP↓, angioG↓, VEGF↓, ChemoSen↑,
8748- MeSA,    Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia
- in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
Hif1a↓, DDIT4?, p‑Akt↑, P70S6K↑, TumCG↓,
8744- MeSA,    Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells
- in-vitro, Pca, DU145
PKCδ↓, TumCG↓, Apoptosis↑,
8758- MeSA,    Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potential
- vitro+vivo, RCC, 786-O - in-vitro, Kidney, Caki-1
TGF-β1↓, PD-L1↓, VEGF↓, TumCG↓,
2456- MET,    Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer
- in-vitro, BC, MDA-MB-231 - in-vivo, NA, NA
GlucoseCon↓, TumCG↓, HK2↓, p‑AMPK↑, TXNIP↓, *toxicity↓,
2384- MET,    Integration of metabolomics and transcriptomics reveals metformin suppresses thyroid cancer progression via inhibiting glycolysis and restraining DNA replication
- in-vitro, Thyroid, BCPAP - in-vivo, NA, NA - in-vitro, Thyroid, TPC-1
Glycolysis↓, OXPHOS↑, tumCV↓, TumCI↓, TumCMig↓, EMT↓, Apoptosis↑, TumCCA↑, LDHA↓, PKM2↓, IDH1↑, TumCG↓,
2379- MET,    Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
- in-vitro, Bladder, T24/HTB-9 - in-vitro, BC, UMUC3
PKM2↓, p‑STAT3↓, TumCG↓, Synergy↑, chemoP↑, AMPK↑,
5532- MF,    Magnetoporation: New Method for Permeabilization of Cancerous Cells to Hydrophilic Drugs
- in-vivo, BC, NA
Dose↑, CellMemb↑, eff↝, other↝, TumCG↓,
2255- MF,    Pulsed Electromagnetic Fields Induce Skeletal Muscle Cell Repair by Sustaining the Expression of Proteins Involved in the Response to Cellular Damage and Oxidative Stress
- in-vitro, Nor, SkMC
*HSP70/HSPA5↑, *Apoptosis↓, *Inflam↓, *Trx↓, *PONs↓, *SOD2↓, *TumCG↑, *Diff↑, *HIF2a↑, *Cyt‑c↑, P21↑,
2261- MF,    Tumor-specific inhibition with magnetic field
- in-vitro, Nor, GP-293 - in-vitro, Liver, HepG2 - in-vitro, Lung, A549
ROS↑, Ca+2↓, Apoptosis↑, *selectivity↑, TumCG↓, *i-Ca+2↓, i-Ca+2↑,
2260- MF,    Alternative magnetic field exposure suppresses tumor growth via metabolic reprogramming
- in-vitro, GBM, U87MG - in-vitro, GBM, LN229 - in-vivo, NA, NA
TumCP↓, TumCG↓, OS↑, ROS↑, SOD2↑, eff↓, ECAR↓, OCR↑, selectivity↑, *toxicity∅, TumVol↓, PGC-1α↑, OXPHOS↑, Glycolysis↓, PKM2↓,
8489- MF,    Pulsed electromagnetic fields induce ferroptosis in osteosarcoma cells and promote osteogenic differentiation
- in-vitro, OS, U2OS - in-vitro, OS, MG63
TumCP↓, TumCMig↓, Ferroptosis↑, GPx4↓, xCT/SLC7A11↓, BMD↑, selectivity↑, Dose↝, TumCG↓, Dose↝, OS↑, ROS↑, MDA↑, Iron↑, ChemoSen↑, TOP2↑, radioP↑,
8486- MF,    Silent forces, hidden currents: the influence of static magnetic field stimulation on tumor biophysics
- Review, Var, NA
Ca+2↑, TumCG↓, MMP↓, CellMemb↑, SOX2↓, Nanog↓, cMyc↓, CD44↓, CD133↓, P53↑, ROS↑, DNAdam↑, CDK1↓, CycB/CCNB1↓, TumCCA↑, TumCP↓, pH↓, TumCP↓, Telomerase↓, ChemoSen↑, TRPV1↝, Bax:Bcl2↑, Casp3↑, Akt↓, mTOR↓, mitA↑, ROS↓, P-gp/ABCB1↓, MDR1↓, RadioS↑, Apoptosis↑, GSH↓, lipid-P↑, Iron↑, Iron↓, Fenton↑,
3464- MF,    Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology
- Review, Var, NA
AntiTum↑, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↑, Diff↑, angioG↓, TumMeta↓, EPR↑, ChemoSen↑, ROS↑, DNAdam↑, P53↑, Akt↓, MAPK↑, Casp9↑, VEGFR2/KDR/Flk1↓, P-gp/ABCB1↓,
3466- MF,    The effect of magnetic fields on tumor occurrence and progression: Recent advances
- Review, Var, NA
angioG↓, ROS↝, EGFR↝, TumCG↓,
7390- MF,    A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP
TumCG↓, Apoptosis↑, TumCCA↑, cl‑Casp3↑, ROS↑, eff↓, Dose↝, Dose↝, H2O2↑,
7387- MF,    Effects of Sinusoidal Magnetic Field Observed on Cell Proliferation, Ion Concentration, and Osmolarity in Two Human Cancer Cell Lines
- in-vitro, AML, HL-60 - in-vitro, adrenal, SK-HEP-1
Dose↝, TumCG↓, Na+↑, K+↑,
526- MF,    Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vitro, Pca, HeLa - vitro+vivo, Melanoma, B16-BL6 - in-vitro, Nor, HEK293
TumCG↓, Ca+2↑, selectivity↑, *Ca+2∅, ROS↑, HSP70/HSPA5↑, AntiCan↑,
538- MF,    The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift
- in-vitro, BC, MDA-MB-231 - in-vitro, Melanoma, MSTO-211H
TumCG↓, Ca+2↑, COX2/PTGS2↓, ATP↑, MMP↑, ROS↑, OXPHOS↑, mitResp↑,
495- MF,    How a High-Gradient Magnetic Field Could Affect Cell Life
- in-vitro, Cerv, HeLa
Apoptosis↑, CellMemb↑, TumCG↓,
497- MF,    In Vitro and in Vivo Study of the Effect of Osteogenic Pulsed Electromagnetic Fields on Breast and Lung Cancer Cells
- vitro+vivo, BC, MCF7 - vitro+vivo, Lung, A549
TumCG↓, TumVol↓, Casp3↑, Casp7↑, Apoptosis↑, DNAdam↑, TumCCA↑, ChemoSen↑, EPR↑,
502- MF,    Electromagnetic field investigation on different cancer cell lines
- in-vitro, BC, MDA-MB-231 - in-vitro, Colon, SW480 - in-vitro, CRC, HCT116
TumCG↓, Apoptosis↑,
504- MF,    Effect of Magnetic Fields on Tumor Growth and Viability
- in-vivo, Var, NA
TumCG↓,
507- MF,    Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism
- in-vitro, Liver, HepG2 - in-vitro, Lung, A549 - in-vitro, Nor, GP-293
MMP↓, TumCG↓, ROS↑, *Ca+2↓, Ca+2↑, selectivity↑, i-pH↑,
513- MF,    Exposure to a specific time-varying electromagnetic field inhibits cell proliferation via cAMP and ERK signaling in cancer cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468 - in-vitro, BC, MCF7 - in-vivo, Pca, HeLa
TumCG↓, p‑ERK↑, cAMP⇅,
517- MF,  Rad,    Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis
- in-vivo, BC, MDA-MB-231
TumMeta↓, TumCG↓,

Showing Research Papers: 651 to 700 of 989
Prev Page 14 of 20 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 989

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 6,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 5,   Catalase↑, 4,   ENOX2↓, 2,   Fenton↑, 7,   GPx↓, 3,   GPx↑, 4,   GPx4↓, 19,   GSH↓, 52,   GSH↑, 3,   i-GSH↓, 1,   GSH/GSSG↓, 5,   GSR↓, 1,   GSR↑, 1,   GSSG↓, 1,   GSTs↓, 1,   H2O2↓, 4,   H2O2↑, 10,   i-H2O2↑, 1,   mt-H2O2↑, 1,   HO-1↓, 8,   HO-1↑, 11,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 11,   Iron∅, 1,   i-Iron↑, 3,   c-Iron↑, 1,   Keap1↑, 1,   lipid-P↓, 4,   lipid-P↑, 20,   MDA↓, 2,   MDA↑, 11,   NADH↓, 1,   NADHdeh?, 1,   NADPH/NADP+↓, 2,   NOX2↑, 1,   NQO1?, 1,   NQO1↓, 1,   NQO1↑, 3,   Nrf1↓, 1,   Nrf1↑, 1,   NRF2↓, 15,   NRF2↑, 16,   NRF2↝, 1,   ox-PrxI↑, 1,   RNS↑, 2,   ROMO1↑, 1,   ROS?, 3,   ROS↓, 21,   ROS↑, 274,   ROS⇅, 3,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 1,   mt-ROS↑, 9,   SOD↓, 5,   SOD↑, 4,   SOD1↓, 2,   SOD1↑, 1,   SOD2↓, 4,   SOD2↑, 6,   TAC↓, 3,   TBARS↓, 1,   Thiols↓, 1,   i-Thiols↓, 1,   TKT↝, 1,   TOS↑, 1,   Trx↓, 2,   Trx↑, 1,   Trx1↓, 2,   ox-Trx1↑, 1,   TrxR↓, 7,   TrxR↑, 1,   TrxR1↓, 3,   xCT/SLC7A11↓, 12,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 3,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 3,   IronCh↑, 1,   LIP↑, 1,   NCOA4↑, 2,   Tf↑, 1,   TfR1/CD71↓, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 3,   p‑CDC2↓, 1,   CDC25↓, 10,   CDC25↑, 2,   CDC25↝, 1,   compI↓, 2,   compIII↓, 1,   EGF↓, 2,   ETC↓, 8,   HSP60/HSPD1↓, 4,   HSP60/HSPD1↑, 1,   Insulin↓, 3,   mitResp↓, 7,   mitResp↑, 2,   mtDam?, 1,   mtDam↓, 2,   mtDam↑, 26,   OCR↓, 10,   OCR↑, 5,   OXPHOS↓, 5,   OXPHOS↑, 10,   mt-OXPHOS↓, 1,   PDH↓, 2,   PDH↑, 6,   p‑PDH↓, 1,   PGC-1α↓, 1,   PGC-1α↑, 1,   PHB↑, 1,   PINK1↑, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 3,   ACC↓, 1,   ACC-α↓, 2,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 5,   ACSL4↑, 3,   Alanine↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AMP↓, 1,   AMPK↓, 2,   AMPK↑, 23,   AMPK↝, 1,   p‑AMPK↑, 4,   ARG↓, 1,   ATGL/PNPLA2↓, 1,   ATP↓, 38,   ATP↑, 3,   i-ATP↑, 1,   Buty↑, 1,   CAIX/CA9↓, 1,   CAIX/CA9↑, 1,   cAMP↓, 1,   cAMP⇅, 1,   i-citrate↑, 1,   CRM↑, 3,   DHODH↓, 1,   ECAR↓, 7,   ECAR∅, 1,   ENO1↓, 3,   FABP4↑, 1,   FABP5/E-FABP↓, 1,   FASN↓, 7,   FDG↓, 1,   FFA/NEFA↓, 1,   G6PD↓, 1,   GALNT10↓, 1,   GAPDH↓, 4,   GLS↓, 1,   glucoNG↓, 1,   glucose↓, 2,   GlucoseCon↓, 26,   GlucoseCon↑, 3,   GlutMet↓, 1,   Glycine↓, 1,   Glycolysis↓, 57,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 4,   p‑GSK‐3β↓, 2,   p‑GSK‐3β↑, 1,   HK2↓, 25,   HK2∅, 1,   HMG-CoA↓, 7,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   IDH1↑, 1,   KeyT↑, 1,   lactateProd↓, 29,   lactateProd↑, 2,   LDHA↓, 19,   LDHA∅, 1,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 2,   MATs↓, 1,   MCT4↓, 2,   MethCyc↓, 1,   NAD↓, 2,   NADPH↓, 1,   NADPH↑, 1,   NPC1L1↓, 1,   PA↑, 2,   PDK1 / PDPK1↓, 8,   PDKs↓, 4,   PFK↓, 4,   PFK1↓, 5,   PFKP↓, 3,   PKM1↑, 1,   PKM2↓, 21,   p‑PKM2↓, 1,   polyA↓, 1,   PPP↓, 2,   Pyruv↓, 3,   Pyruv↑, 1,   R5P↝, 1,   SCFAs↑, 1,   SIRT1↓, 8,   SIRT1↑, 3,   SREBF2↓, 1,   SREBP1/SREBF1↓, 4,   TCA↓, 2,   TCA↑, 2,   TPI↓, 1,   TS↓, 1,   Warburg↓, 14,   Warburg↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 11,   APAF1↑, 1,   Apoptosis↓, 12,   Apoptosis↑, 381,   Apoptosis∅, 2,   mt-Apoptosis↑, 1,   ASC↑, 1,   ASK1↑, 1,   BAD↓, 3,   BAD↑, 3,   Bak↑, 3,   BAX↓, 2,   BAX↑, 113,   BAX↝, 1,   Bax:Bcl2↑, 32,   Bcl-2?, 1,   Bcl-2↓, 150,   Bcl-2↑, 1,   Bcl-xL↓, 36,   Bcl-xL↑, 3,   BID↓, 1,   BID↑, 5,   cl‑BID↑, 1,   BIM↑, 6,   BNIP3↑, 1,   BNIP3↝, 1,   Casp↑, 38,   Casp↝, 1,   Casp1↓, 2,   Casp1↑, 1,   cl‑Casp1↑, 1,   Casp12↑, 1,   Casp3?, 1,   Casp3↓, 3,   Casp3↑, 134,   cl‑Casp3↓, 1,   cl‑Casp3↑, 52,   proCasp3↓, 1,   CASP4↑, 2,   Casp6↓, 1,   Casp6↑, 1,   Casp7↑, 17,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 32,   cl‑Casp8↑, 11,   Casp9↓, 1,   Casp9↑, 65,   p‑Casp9↑, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 12,   cFLIP↓, 2,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 77,   Cyt‑c↝, 1,   cl‑Cyt‑c↑, 1,   Diablo↑, 1,   DR5↑, 11,   Endon↑, 1,   FADD↑, 3,   Fap1↓, 1,   Fas↓, 4,   Fas↑, 7,   FasL↓, 2,   FasL↑, 5,   Ferroptosis↓, 1,   Ferroptosis↑, 31,   GSDMC↑, 1,   GSDMD↑, 1,   cl‑GSDMD↑, 1,   cl‑GSDME↑, 3,   GSDME-N↑, 1,   HEY1↓, 2,   IAP1↓, 7,   IAP2/BIRC3↓, 3,   ICD↑, 2,   iNOS↓, 4,   Mcl-1↓, 17,   MDM2↓, 6,   MDM2↑, 1,   MLKL↑, 2,   p‑MLKL↓, 1,   MOMP↑, 2,   Necroptosis↑, 4,   necrosis↑, 6,   NOXA↑, 3,   p38↓, 5,   p38↑, 13,   p‑p38↓, 3,   p‑p38↑, 3,   PUMA↑, 3,   Pyro↑, 11,   RIP3↑, 2,   p‑RIP3↑, 2,   survivin↓, 48,   survivin↑, 1,   TNFR 1↑, 1,   TRAIL↑, 2,   TRAILR↑, 1,   TumCD↓, 2,   TumCD↑, 26,   TumCD∅, 1,   TUNEL↑, 1,   XIAP↓, 17,   YAP/TEAD↓, 10,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

ABL1↓, 1,   Akt↓, 117,   Akt↑, 6,   p‑Akt↓, 41,   p‑Akt↑, 1,   AKT1↓, 4,   BCAP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   CaMKII ?, 1,   CaMKII ↓, 3,   CIP2A↓, 1,   cMET↓, 5,   CREB↓, 2,   p‑CREB↓, 1,   cSrc↓, 1,   DDIT4?, 1,   DYRK1B↓, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 24,   ERK↑, 6,   ERK↝, 1,   p‑ERK↓, 15,   p‑ERK↑, 3,   e-ERK↑, 1,   FLT3↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 3,   Hippo↑, 1,   IGF-1R↓, 4,   p‑IGF-1R↓, 1,   IGFR↓, 3,   p‑IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB↑, 1,   p‑IκB↓, 2,   JAK↓, 4,   JAK1?, 1,   JAK1↓, 3,   p‑JAK1↓, 2,   JAK2↓, 13,   p‑JAK2↓, 4,   JNK↓, 3,   JNK↑, 15,   JNK↝, 1,   p‑JNK↓, 2,   p‑JNK↑, 3,   cl‑JNK↑, 1,   LIFR/CD118↓, 1,   MAPK↓, 18,   MAPK↑, 11,   p‑MAPK↑, 2,   MARK4↓, 1,   MEK↓, 3,   MEK↑, 1,   p‑MEK↓, 1,   mTOR↓, 64,   mTOR↑, 7,   p‑mTOR↓, 8,   p‑mTOR↑, 1,   mTORC2↓, 2,   mTORC2↑, 1,   NIK↓, 1,   OR13G1?, 1,   p‑p70S6↓, 2,   P70S6K↓, 4,   P70S6K↑, 1,   p‑P70S6K↓, 2,   p‑P70S6K↑, 1,   PDE3B↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 3,   PDGFRB↓, 1,   PI3K↓, 79,   PI3K↑, 2,   PI3K↝, 1,   p‑PI3K↓, 6,   PI3K/Akt↓, 4,   PI3K/Akt↑, 1,   p‑PI3k/Akt/mTOR↓, 1,   PKA↓, 2,   p‑PKA↓, 1,   PKCδ↓, 5,   p‑PKCδ↓, 2,   PPP2R1A↑, 1,   PTEN↓, 3,   PTEN↑, 15,   PTK2B / PYK2↓, 1,   Raf↓, 3,   RAS↓, 5,   Rictor↓, 1,   RIP1↑, 1,   RSK2/RPS6KA3/p90RSK2↓, 1,   Sp1/3/4↓, 12,   Sp1/3/4↑, 1,   Src↓, 3,   STAT↓, 4,   STAT3↓, 64,   STAT3↑, 1,   STAT3↝, 1,   p‑STAT3↓, 16,   p‑STAT3↑, 2,   STAT4↑, 1,   STAT5↓, 2,   p‑STAT5↓, 1,   SYK↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF1↓, 1,   ATF2↓, 1,   ATF3↑, 2,   ATF4↑, 10,   BRD4↓, 1,   CBP↓, 1,   ChrMod↑, 2,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 37,   cMyc↑, 1,   DNMT1↓, 6,   DNMT3A↓, 1,   DNMT3B↓, 2,   DNMTs↓, 5,   EZH2↓, 3,   FOXM1↓, 2,   FOXO1↓, 2,   FOXO1↑, 3,   FOXO3↓, 1,   FOXO3↑, 3,   FOXO3↝, 1,   p‑FOXO3↓, 1,   GATA3↓, 1,   H19↑, 1,   H3↓, 2,   H3↑, 1,   ac‑H3↑, 2,   H3K4↓, 1,   H3K9↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 2,   HATs↑, 1,   HDAC↓, 27,   HDAC↑, 1,   HDAC1↓, 2,   HDAC2↓, 4,   HDAC3↓, 2,   HDAC4↓, 1,   HDAC6↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   KLF2↓, 1,   KLF5↓, 1,   miR-106b↓, 1,   miR-122-5p↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-140↑, 1,   miR-141↑, 1,   miR-155↓, 1,   miR-199↓, 1,   miR-200b↑, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-205↑, 2,   miR-21↓, 3,   miR-22↑, 1,   miR-27a-3p↓, 2,   miR-29b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   miR-330-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 4,   miR-375↑, 1,   miR-486↑, 1,   miR-542↓, 1,   Myc↓, 5,   MYCN↑, 1,   OCT4↓, 15,   OLIG2↓, 1,   other?, 1,   other↓, 4,   other↑, 8,   other↝, 27,   PhotoS↑, 1,   SD↑, 1,   SOX2↓, 9,   SOX9↓, 2,   SUV39H↓, 7,   SUZ12↓, 1,   TCF-4↓, 1,   tumCV?, 1,   tumCV↓, 81,   tumCV∅, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 2,   CHOP/DDIT3↑, 18,   CHOP/DDIT3↝, 1,   eIF2α↑, 5,   p‑eIF2α↑, 6,   ER Stress↑, 39,   ERStress↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 12,   GRP94↑, 1,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 2,   HSP72↑, 1,   HSP90↓, 7,   HTRA↓, 2,   IRE1↑, 4,   NPL4↓, 1,   PDI↑, 1,   PERK↓, 1,   PERK↑, 8,   p‑PERK↑, 1,   Proteasome↓, 3,   UPR↓, 1,   UPR↑, 11,   XBP-1↑, 1,   XBP-1↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG3↓, 1,   ATG3↑, 1,   ATG5↑, 6,   ATG7↑, 1,   autoF↓, 1,   autolysosome↑, 1,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 13,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 5,   LC3B↑, 3,   LC3B-II↑, 3,   LC3II↓, 1,   LC3II↑, 11,   LC3s↓, 1,   LC3s↑, 2,   lysosome↓, 1,   MitoP↑, 1,   p62↓, 7,   p62↑, 6,   PARK2↑, 1,   SESN2↑, 1,   TumAuto↓, 3,   TumAuto↑, 57,   TumAuto↝, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 1,   p‑ATM↑, 1,   ATR↑, 1,   DFF45↓, 1,   DNAdam↑, 64,   DNAdam⇅, 1,   mt-DNAdam↑, 1,   DNArepair↓, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   MGMT↓, 1,   NHEJ↓, 1,   p16↑, 1,   P53?, 1,   P53↓, 3,   P53↑, 65,   P53↝, 3,   P53∅, 1,   p‑P53↑, 6,   PARP↓, 2,   PARP↑, 14,   p‑PARP↑, 2,   cl‑PARP↑, 63,   PARP1↓, 2,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 23,   SAPK↑, 1,   Telomerase↓, 5,   TOP1↓, 2,   TOP2↓, 4,   TOP2↑, 1,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 9,   γH2AX↝, 1,   p‑γH2AX↑, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↓, 1,   AURKB↑, 1,   BRD4↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 15,   CDK1↑, 1,   CDK1↝, 1,   CDK1/2/5/9↓, 1,   CDK2↓, 17,   CDK2↑, 2,   p‑CDK2↓, 1,   CDK4↓, 27,   CDK4↑, 3,   CDK4/6↓, 1,   CDK6↓, 7,   CDK6↑, 3,   CDK8↓, 1,   cellSen↑, 1,   CHK1↓, 2,   CHK1↑, 1,   CHK1↝, 1,   Chk2↑, 2,   p‑Chk2↑, 1,   Cyc↓, 3,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 21,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 74,   cycD1/CCND1↑, 1,   cycE/CCNE↓, 9,   cycE/CCNE↑, 1,   cycE1↓, 2,   cycF↑, 1,   E2Fs↓, 4,   GADD45A↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   mitA↑, 2,   p19↑, 1,   P21↓, 3,   P21↑, 58,   p27/CDKN1B↓, 2,   p27/CDKN1B↑, 19,   PLK1↓, 1,   pRB↓, 1,   pRB↑, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   cl‑RB1↓, 1,   Securin↓, 2,   TubPol↓, 2,   TumCCA↓, 7,   TumCCA↑, 256,   β-Tubulin↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   4E-BP1↑, 1,   p‑4E-BP1↓, 1,   ALDH↓, 7,   ALDH1A1↓, 2,   ALDH1A3↓, 1,   Axin2↑, 1,   BMI1↓, 4,   BMP7/OP1↓, 1,   CD133↓, 12,   CD133↑, 1,   CD24↓, 4,   CD34↓, 2,   CEBPB?, 1,   cFos↓, 4,   CSCs↓, 49,   CSCs↑, 2,   CSCsMark↓, 1,   Diff↑, 13,   EP4/PTGER4↑, 1,   FGF↓, 1,   FOSL1↑, 1,   Gli↓, 1,   Gli1↓, 20,   Gli1∅, 1,   GTPBP4↓, 1,   HH?, 1,   HH↓, 20,   HMGCR↓, 2,   HMGCR↑, 1,   Id1↓, 1,   IGF-1↓, 10,   IGF-1↑, 1,   IGFBP3↓, 1,   IGFBP3↑, 2,   Ki-67↓, 57,   Ki-67↑, 1,   Let-7↑, 1,   LRP6↓, 2,   mTORC1↓, 6,   Nanog↓, 12,   Nestin↓, 1,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 8,   NOTCH1↝, 1,   NOTCH2↑, 2,   NOTCH3↓, 3,   p300↓, 1,   Piezo1↑, 2,   PTCH1↓, 8,   PTCH2↓, 1,   Shh↓, 7,   Smo↓, 8,   Smo∅, 1,   STAT1↓, 1,   Sufu↓, 1,   Sufu↑, 1,   TAZ↓, 2,   TumCG?, 11,   TumCG↓, 962,   TumCG↑, 18,   TumCG⇅, 2,   TumCG↝, 3,   TumCG∅, 6,   TumCP↓, 214,   TumCP↑, 6,   Wnt↓, 27,   Wnt/(β-catenin)↓, 4,  

Migration(tgid=13) ⓘ

AGRN↓, 1,   AKR1C2↓, 1,   AntiAg↑, 2,   AP-1↓, 4,   AP-1↝, 1,   ARG1/2↑, 1,   CA↓, 2,   Ca+2↓, 2,   Ca+2↑, 25,   Ca+2↝, 2,   i-Ca+2↑, 4,   Cal1↑, 1,   Cav1↓, 1,   Cav1↑, 1,   CCAT1↓, 1,   CD11b↓, 1,   i-Chl↑, 1,   COL11A1↓, 1,   CTNNB1↓, 1,   E-cadherin↓, 2,   E-cadherin↑, 43,   E-cadherin↝, 1,   EMT?, 1,   EMT↓, 64,   EMT↝, 1,   EpCAM↓, 1,   FAK↓, 11,   FAK↑, 1,   Fibronectin↓, 2,   Galectin-9↓, 1,   GIT1↓, 1,   GLI2↓, 5,   ITGA5↓, 2,   ITGB1↓, 3,   LEF1↓, 2,   MALAT1↓, 2,   MET↑, 1,   MMP1↓, 3,   MMP13↓, 2,   MMP15↓, 1,   MMP2↓, 54,   proMMP2↓, 1,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 71,   MMPs↓, 8,   MTA1↓, 1,   MUC1↓, 1,   MUC1-C↓, 1,   N-cadherin↓, 27,   N-cadherin↝, 1,   Na+↑, 2,   NCAM↓, 1,   NFAT↑, 1,   p‑p44↓, 1,   PAK1↓, 1,   PCBP1↓, 1,   PDGF↓, 1,   Rac1↓, 1,   RECK↑, 1,   Rho↓, 2,   ROCK1↓, 1,   Slug↓, 11,   p‑SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 18,   SPARC↑, 2,   talin↓, 1,   TET1↓, 1,   TGF-β↓, 7,   TGF-β1↓, 2,   TIMP1↑, 4,   TIMP2↑, 4,   TRIB3↑, 2,   TSP-1↑, 2,   TumCA↓, 3,   TumCI?, 2,   TumCI↓, 112,   TumCI↑, 2,   TumCMig?, 2,   TumCMig↓, 123,   TumCMig↑, 2,   TumMeta?, 1,   TumMeta↓, 91,   TumMeta↑, 5,   TumPF↓, 4,   Twist↓, 8,   TXNIP↓, 1,   TXNIP↑, 2,   uPA↓, 7,   uPAR↓, 2,   Vim↓, 28,   Zeb1↓, 8,   Zeb1↑, 1,   ZEB2↓, 1,   α-SMA↓, 2,   α-tubulin↓, 4,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 38,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 89,   angioG↑, 2,   CD31/PECAM-1↓, 8,   CD31/PECAM-1↑, 1,   ECM/TCF↓, 3,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 3,   Hif1a↓, 50,   Hif1a↑, 1,   Hif1a↝, 1,   NO↓, 5,   NO↑, 2,   VCAM-1↓, 3,   VEGF↓, 84,   VEGF↑, 2,   VEGFR1↓, 2,   VEGFR2/KDR/Flk1↓, 13,   VM↓, 1,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↑, 7,   CellMemb↓, 1,   CellMemb↑, 4,   CLDN1↓, 1,   CLDN7↑, 1,   EPR↑, 9,   GLUT1↓, 11,   GLUT1↑, 1,   GLUT2↓, 1,   GLUT3↓, 1,   GLUT3↑, 1,   GLUT4↓, 2,   IBI↑, 1,   K+↑, 1,   memfluid↓, 1,   MMP?, 1,   MMP↓, 134,   MMP↑, 5,   MPT↑, 4,   Na+↑, 2,   NHE1↓, 1,   OCLN↑, 1,   TRPM7↑, 2,   TRPV1↓, 1,   TRPV1↑, 1,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC∅, 1,   CCL20↑, 1,   CD155↓, 1,   CD25+↓, 2,   CD4+↓, 3,   CD4+↑, 10,   CD44↓, 18,   CD44↝, 1,   CD47↓, 1,   CD8+↑, 12,   cDC2↓, 2,   p‑cDC2↓, 2,   cGAS–STING↑, 1,   CLP↑, 1,   COX1?, 1,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 31,   COX2/PTGS2↑, 2,   CXCc↓, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCL9↓, 1,   CXCR4↓, 9,   DCells↑, 3,   DR4↑, 2,   DR6↑, 1,   FOXP3↓, 1,   FoxP3+↓, 2,   Gal-3↓, 2,   GM-CSF↓, 3,   HLA-I/II↑, 1,   HMGB1↓, 4,   HMGB1↑, 1,   ICAM-1↓, 8,   IFN-γ↓, 2,   IFN-γ↑, 3,   IL1↓, 5,   IL1↑, 2,   IL10↓, 2,   IL10↑, 2,   IL12↓, 1,   IL12↑, 4,   IL18↑, 2,   IL1β↓, 9,   IL1β↑, 1,   IL2↓, 3,   IL2↑, 3,   IL4↑, 1,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   IL8↓, 7,   Imm↑, 22,   Imm↝, 1,   Inflam↓, 27,   Inflam↝, 1,   LPS↓, 1,   pol-M1↑, 1,   M2 MC↓, 1,   M2 MC↑, 1,   pol-M2 MC↓, 2,   Macrophages↑, 1,   MCP1/CCL2↓, 2,   MDSCs↓, 1,   mPGES-1↓, 1,   MyD88↓, 1,   NAF1↓, 1,   NF-kB↓, 111,   NF-kB↑, 5,   NF-kB⇅, 1,   NF-kB↝, 1,   p‑NF-kB↓, 3,   NK cell↑, 8,   NLRP3↓, 2,   NLRP3↑, 3,   p50↓, 1,   p65↓, 7,   p‑p65↓, 4,   PD-1↓, 2,   PD-L1↓, 19,   PD-L2↓, 1,   PGE2↓, 9,   PSA↓, 12,   T-Cell↑, 8,   TCF↓, 3,   Th1 response↑, 1,   TILs↑, 2,   TIM-3↓, 2,   TIRAP↓, 1,   TLR4↓, 3,   TLR4↝, 1,   TNF-α?, 1,   TNF-α↓, 13,   TNF-α↑, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GFAP↓, 1,   pH↓, 2,   pH↑, 3,   pH↝, 1,   e-pH↑, 10,   i-pH↓, 1,   i-pH↑, 1,   TAMS↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

SYN1↑, 1,  

Protein Aggregation(tgid=19) ⓘ

BACE/β-secretase↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACTH↓, 1,   AR↓, 18,   COMT↑, 1,   CYP11A1↓, 1,   CYP19↓, 1,   DHT↓, 1,   ER-α36↓, 1,   ER(estro)↓, 2,   ERα/ESR1↓, 2,   ERβ/ESR2↑, 2,   FGF21↓, 1,   GR↓, 1,   HSD3B↓, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↑, 2,   RANKL↓, 2,   SRD5A1↑, 1,   StAR↓, 1,   SXR↓, 1,   testos↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 1,   ABCG2↓, 1,   BioAv↓, 27,   BioAv↑, 24,   BioAv↝, 11,   ChemoSen?, 1,   ChemoSen↓, 4,   ChemoSen↑, 155,   ChemoSen∅, 2,   CompStab↓, 2,   CompStab↑, 1,   CompStab↝, 2,   CYP1A1↓, 1,   CYP1A1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 4,   Dose↓, 6,   Dose↑, 7,   Dose⇅, 2,   Dose↝, 104,   Dose∅, 13,   DrugR↓, 1,   eff?, 1,   eff↓, 84,   eff↑, 107,   eff↝, 16,   eff∅, 2,   Half-Life↓, 6,   Half-Life↑, 2,   Half-Life↝, 8,   Half-Life∅, 2,   MDR1↓, 6,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 11,   P-gp/ABCB1↝, 1,   P-gp/ABCB1∅, 1,   P450↓, 2,   P450↑, 1,   RadioS?, 1,   RadioS↑, 44,   RadioS↝, 1,   selectivity?, 1,   selectivity↓, 3,   selectivity↑, 128,   selectivity↝, 1,   selectivity∅, 1,   Synergy↑, 100,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 5,   ALAT∅, 1,   AR↓, 18,   ascitic↓, 2,   AST↓, 4,   AST∅, 1,   BG↓, 4,   BMD↑, 3,   BP↓, 1,   BRAF↓, 2,   BRAF↑, 1,   EGFR↓, 29,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 2,   EZH2↓, 3,   Ferritin↓, 3,   Ferritin↑, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 10,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 3,   IL6?, 1,   IL6↓, 22,   IL6↑, 2,   KeyT↑, 1,   LDH↓, 8,   LDH↑, 2,   p‑LDH↓, 1,   Myc↓, 5,   PD-L1↓, 19,   PSA↓, 12,   PSADT↑, 1,   SUZ12↓, 1,   TG/TAG↓, 1,   TP53↑, 1,   TRIB3↑, 2,   Tumccf↓, 3,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiArt↑, 1,   AntiCan↓, 1,   AntiCan↑, 62,   AntiCan?, 1,   antiCG↓, 1,   antiNeop↑, 4,   antiNeop∅, 1,   AntiTum↑, 40,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 3,   cardioP↑, 7,   CardioT↓, 1,   chemoP↓, 1,   chemoP↑, 24,   chemoPv↑, 19,   ChemoSideEff↓, 7,   cognitive↑, 1,   fatigue∅, 1,   FTO↑, 1,   hepatoP↑, 5,   hepatoP∅, 1,   kidSt↓, 1,   motorD↑, 1,   neuroP↑, 5,   Obesity↓, 1,   OS↑, 62,   OS⇅, 1,   Pain↓, 5,   PDE4↓, 1,   QoL↑, 7,   QoL∅, 2,   radioP↑, 7,   Remission↑, 5,   Risk↓, 28,   Risk↑, 1,   Sleep↑, 1,   Strength↑, 4,   toxicity↓, 49,   toxicity↑, 4,   toxicity⇅, 1,   toxicity↝, 14,   toxicity∅, 9,   TumNum↓, 3,   TumVol↓, 38,   TumW↓, 22,   Weight↑, 4,   Weight∅, 10,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 2,   Bacteria↓, 3,   GutMicro↑, 13,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 8,  
Total Targets: 1168

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 7,   antiOx↑, 50,   ARE↑, 1,   Catalase↑, 12,   DPPH↓, 1,   GPx↑, 12,   GPx1↑, 1,   GSH↓, 2,   GSH↑, 19,   GSR↑, 3,   GSTs↑, 6,   H2O2↓, 2,   HO-1↑, 11,   lipid-P↓, 14,   MDA↓, 11,   NQO1↑, 1,   NRF2↑, 16,   ROS↓, 52,   ROS↑, 4,   ROS∅, 2,   mt-ROS↓, 1,   SOD↑, 18,   SOD1↑, 1,   SOD2↓, 1,   TBARS↓, 1,   Trx↓, 1,   Trx↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

EGF↓, 1,   ETC↝, 1,   mitResp↑, 1,   OCR↓, 1,   OXPHOS↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 5,   adiP↑, 1,   ALAT?, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 4,   ATP↓, 1,   ATP↑, 1,   ECAR∅, 1,   glucose↓, 3,   GlucoseCon↑, 3,   GSK‐3β↓, 1,   GSK‐3β↑, 1,   LDL↓, 6,   lipidLev↓, 1,   NAD↓, 1,   NADPH↓, 1,   PONs↓, 1,   SIRT1↑, 6,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 5,   Apoptosis↑, 1,   ASC↓, 1,   BAX↓, 3,   BAX↑, 1,   Bax:Bcl2↓, 1,   Bcl-2↓, 1,   Bcl-2↑, 1,   Casp↓, 1,   Casp1↓, 2,   Casp3↓, 4,   Casp3↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 2,   Cyt‑c↓, 2,   Cyt‑c↑, 1,   Ferroptosis↑, 1,   iNOS↓, 7,   iNOS↑, 1,   necrosis↓, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   p‑Akt↑, 1,   Akt2↓, 1,   CREB↑, 1,   p‑CREB↑, 1,   ERK↑, 2,   IKKα↓, 1,   JNK↓, 1,   JNK↑, 1,   MAPK↓, 2,   MAPK↑, 1,   mTOR↓, 2,   mTOR↑, 1,   PTEN↓, 1,   STAT↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   ATF4↓, 1,   cJun↓, 1,   cMyc↓, 1,   FOXO3↑, 1,   other?, 1,   other↓, 2,   other↑, 6,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   HSP27↑, 1,   HSP70/HSPA5↑, 1,   HSPs↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   LC3II↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 2,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   GADD34↓, 1,   P21↓, 2,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Diff↑, 1,   IGF-1↑, 1,   neuroG↑, 1,   TumCG↓, 5,   TumCG↑, 1,   TumCG∅, 1,   TumCP↓, 1,   tyrosinase↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AP-1↓, 2,   BACH1↓, 1,   Ca+2↓, 3,   Ca+2↑, 2,   Ca+2∅, 1,   i-Ca+2↓, 1,   EMT↓, 1,   MLC2/MYL9↝, 1,   MMP9↓, 1,   MMPs↓, 1,   Snail↑, 1,   TGF-β↓, 2,   TIMP1↓, 1,   TumCI↓, 1,   TumMeta↓, 1,   Twist↑, 1,   Vim↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 1,   HIF-1↓, 1,   Hif1a↓, 1,   Hif1a↑, 1,   HIF2a↑, 1,   NO↓, 5,   VCAM-1↓, 2,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 3,   BBB↝, 2,   CellMemb↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 2,   MMP↓, 1,   MMP↑, 2,   OCLN↝, 1,   TJ↑, 1,   TRPC1↓, 1,   TRPV1↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD19↑, 1,   CD4+↑, 2,   CD8+↑, 1,   COX1↓, 3,   COX2/PTGS2↓, 13,   HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 1,   IL10↑, 2,   IL12↓, 1,   IL17↓, 2,   IL1β↓, 7,   IL2↑, 1,   IL6↓, 14,   IL8↓, 2,   Imm↓, 1,   Imm↑, 5,   Inflam↓, 57,   Inflam↑, 1,   IRF3↓, 1,   MyD88↓, 1,   Neut↑, 1,   NF-kB↓, 15,   NK cell↑, 2,   NLRP3↓, 2,   NLRP3↑, 1,   PGE2↓, 5,   TLR2↓, 2,   TLR4↓, 5,   TNF-α↓, 13,   TNF-α↑, 1,   TRIF↓, 1,   VitD↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   Ach↑, 1,   AChE↓, 8,   AChE↑, 1,   AChE↝, 1,   BDNF↓, 1,   BDNF↑, 6,   ChAT↑, 1,   GABA↑, 1,   MAOA↓, 1,   NGF↑, 1,   TrkB↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 6,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv?, 1,   BioAv↓, 11,   BioAv↑, 24,   BioAv↝, 7,   BioEnh↑, 3,   CompStab↑, 1,   CYP3A2↓, 1,   Dose?, 2,   Dose⇅, 1,   Dose↝, 4,   eff↑, 4,   Half-Life↓, 3,   Half-Life↝, 3,   Half-Life∅, 1,   P450↓, 3,   selectivity↑, 3,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 6,   ALP↓, 1,   AST↓, 7,   BMD↑, 2,   BP↓, 3,   colonLen↑, 1,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 14,   LDH↓, 2,   LDH↑, 1,   TC↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 3,   antiAll↑, 3,   AntiArt↑, 4,   AntiCan↑, 6,   AntiDiabetic↑, 8,   AntiTum↑, 2,   cardioP↑, 27,   chemoP↑, 5,   chemoPv↑, 6,   cognitive↑, 12,   DCR∅, 1,   hepatoP↑, 20,   memory↑, 13,   motorD↑, 1,   neuroP↑, 36,   ORR∅, 1,   OS↑, 3,   Pain↓, 2,   PDE4↓, 1,   PFS∅, 1,   QoL↑, 1,   radioP↑, 2,   RenoP↓, 1,   RenoP↑, 4,   Stroke↓, 2,   toxicity↓, 40,   toxicity↑, 3,   toxicity↝, 7,   toxicity∅, 12,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 11,   GutMicro↑, 6,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 2,   Ingr↝, 5,  
Total Targets: 292

Scientific Paper Hit Count for: TumCG, Tumor cell growth
29 Curcumin
29 Magnetic Fields
19 Phenethyl isothiocyanate
17 Quercetin
17 Sulforaphane (mainly Broccoli)
17 Magnetic Field Rotating
14 Berberine
14 EGCG (Epigallocatechin Gallate)
13 Silver-NanoParticles
13 Chemotherapy
13 Shikonin
12 Vitamin C (Ascorbic Acid)
12 Magnolol
12 Bicarbonate(Sodium)
11 Alpha-Lipoic-Acid
11 Melatonin
11 Baicalein
11 Garcinol
11 phytic acid, Inositol hexakisphosphate
10 Benzyl isothiocyanate
10 Capsaicin
10 Apigenin (mainly Parsley)
10 chaetocin
10 Fisetin
9 Cucurbitacin
9 Silymarin (Milk Thistle) silibinin
9 Resveratrol
9 Dichloroacetate
9 Deguelin
9 Formononetin
9 Phenylbutyrate
8 Astragalus
8 Radiotherapy/Radiation
8 Artemisinin
8 salinomycin
8 diet FMD Fasting Mimicking Diet
8 Emodin
8 Gambogic Acid
8 Ginkgetin
8 Honokiol
8 Ivermectin
8 Matrine
8 Magnesium
8 Pterostilbene
8 Urolithin
7 Allyl isothiocyanate
7 Cisplatin
7 Allicin (mainly Garlic)
7 HydroxyCitric Acid
7 Ashwagandha(Withaferin A)
7 immunotherapy
7 Boron
7 Boswellia (frankincense)
7 Crocetin
7 Isoliquiritigenin
7 Lycopene
7 mebendazole
7 methylseleninic acid
6 Metformin
6 Betulinic acid
6 Chrysin
6 Coenzyme Q10
6 Gemcitabine (Gemzar)
6 diet Methionine-Restricted Diet
6 Sulfasalazine
6 Indole-3-carbinol
6 Inulin Prebiotic
6 itraconazole
6 Juglone
6 Rosmarinic acid
6 α-Santalol/Sandalwood oil
5 chitosan
5 doxorubicin
5 Paclitaxel/Taxol
5 Berbamine
5 Beta-Caryophyllene
5 Centella asiatica / Gotu kola → asiaticoside
5 Citric Acid
5 Diindolylmethane
5 Dandelion Root
5 Eugenol
5 Gallic acid
5 Graviola
5 isoquercitrin
5 Linalool
5 Luteolin
4 3-bromopyruvate
4 Fenbendazole
4 Astaxanthin
4 Atorvastatin
4 Dipyridamole
4 Brucea javanica
4 Butyrate
4 Caffeic Acid Phenethyl Ester (CAPE)
4 Cynaropicrin
4 Docosahexaenoic Acid
4 Disulfiram
4 Evodiamine
4 Flaxseed/Linseed
4 Genistein (soy isoflavone)
4 Hydrogen Gas
4 Hyperoside
4 Isobavachalcone
4 Inositol
4 Nimbolide
4 Marjoram (Origanum majorana)
4 Terpinen-4-ol / Tea Tree Oil
4 Piperine
4 Piperlongumine
4 Selenite (Sodium)
4 Thymoquinone
4 Vitamin K2
4 VitK3,menadione
4 Zyflamend
3 Caffeic acid
3 Diclofenac
3 Baicalin
3 Bufalin/Huachansu
3 brusatol
3 Bruteridin(bergamot juice)
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 Carvacrol
3 Celastrol
3 Chlorogenic acid
3 Selenium NanoParticles
3 Copper and Cu NanoParticles
3 Photodynamic Therapy
3 tamoxifen
3 Ellagic acid
3 eicosapentaenoic acid
3 Fucoidan
3 Geraniol
3 Ginger/6-Shogaol/Gingerol
3 Glabrescione B
3 Gossypol/AT-101
3 HydroxyTyrosol
3 MCT, metronomic chemo
3 Isorhamnetin
3 Licochalcone A
3 Licorice
3 Lemongrass Extract/Citral
3 SDG/lignans
3 Modified Citrus Pectin
3 Mangiferin
3 Niclosamide (Niclocide)
3 Patchouli Oil (Pogostemon cablin)
3 Propyl gallate
3 Plumbagin
3 Aflavin-3,3′-digallate
2 2-DeoxyGlucose
2 Auranofin
2 5-fluorouracil
2 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
2 Andrographis
2 Anethole/trans-Anethole
2 Fennel Oil/Foeniculum vulgare
2 Ascorbyl Palmitate
2 Biochanin A
2 Bifidobacterium
2 Bromelain
2 α-Bisabolol / Chamomile oil
2 Carnosic acid
2 Cinnamon
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Polyphenols
2 Chlorella (Chlorella vulgaris)
2 Cyclopamine
2 Oxygen, Hyperbaric
2 diet Short Term Fasting
2 D-limonene
2 Ginkgo biloba-EGb 761
2 ferumoxytol
2 Galloflavin
2 Ginkgo biloba
2 Ginkgolide B
2 Grapeseed extract
2 Hydroxycinnamic-acid
2 iodine
2 Isothiocyanates
2 Isovitexin
2 Kaempferol
2 Lutein
2 Methylene blue
2 Moringin
2 Methylsulfonylmethane
2 Mushroom Chaga, Inonotus obliquus
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Mushroom Maitake
2 Oroxylin-A
2 Oleuropein
2 Orlistat
2 Phycocyanin
2 Psoralidin
2 Hyperthermia
2 EMF
2 Oxaliplatin
2 Spermidine
2 Ursolic acid
2 Vitexin
2 Whole Body Vibration
1 1,8-Cineole
1 Açaí, Euterpe oleracea
1 Anzaroot, Astragalus fasciculifolius Bioss
1 octreotide
1 Acetyl-l-carnitine
1 DTS(dibenzyl trisulphide) from Anamu
1 Angelica archangelica / Garden Angelica
1 Anti-oxidants
1 5-Aminolevulinic acid
1 Aloe anthraquinones
1 beta-glucans
1 temozolomide
1 Bacopa monnieri
1 Black Rice, Oryza sativa
1 Bullatacin
1 Caffeine
1 urea
1 Cat’s Claw
1 Cannabidiol
1 Celecoxib
1 Chocolate
1 Cranberry
1 Calorie Restriction Mimetics
1 Carvone
1 Bicalutamide
1 CUSP9
1 Dichloroacetophenone(2,2-)
1 Dasatinib/Phyrago
1 Bortezomib
1 Date Fruit Extract
1 diet Ketogenic
1 diet Plant based
1 Ormeloxifene (Centchroman)
1 Aspirin
1 Zinc
1 Echinacea
1 PXD, phenoxodiol
1 Sorafenib (brand name Nexavar)
1 Electrical Pulses
1 erastin
1 Eurycomanone
1 Flaxseed Oil
1 Shilajit/Fulvic Acid
1 Ginkgolic acids
1 Hibiscus sabdariffa
1 capecitabine
1 L-Theanine
1 Lactobacillus
1 probiotics
1 Laetrile B17 Amygdalin
1 Lapachol
1 Lasiodin
1 Lactoferrin/Talactoferrin
1 MBE, Maqui berry
1 MCT oil
1 Methyl Jasmonate
1 vp16, etoposide
1 Methylglyoxal
1 magnetic nanoparticles
1 Morin
1 Mistletoe/Viscum album Extracts
1 Naringin
1 Noscapine
1 Aromatherapy
1 Purple Corn / Purple Maize
1 Parthenolide
1 Broccoli
1 raloxifen
1 Salvia officinalis
1 Vorinostat
1 Selenium
1 irinotecan
1 Salvia miltiorrhiza
1 Saikosaponin B1 and D
1 Sutherlandioside D
1 cetuximab
1 Taurine
1 Tomatine
1 triptolide
1 Tumor Treating Fields
1 Turmerones
1 Usnic acid
1 Vitamin B1/Thiamine
1 Vitamin B5,Pantothenic Acid
1 Transarterial Chemoembolization
1 Walnut
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:323  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page